William Mwiti
Dr. William Mwiti is a Kenyan pharmacist and public-health strategist who has spent more than two decades raising the bar for medicine quality and governance across Africa. Trained at the University of Nairobi (BPharm) and the London School of Hygiene & Tropical Medicine (MSc, Public Health), he joined GlaxoSmithKline in 2002 and now serves as Director of Quality & Risk Management for Africa and Developing Countries of Asia, stewarding pharmacovigilance, regulatory affairs, and medical governance in 53 markets.
Mwiti co-authored Kenya’s first Pharmaceutical Industry Code of Practice in 2004 and was a lead technical adviser on the 2008 Anti-Counterfeit Act, a law credited with slashing seizures of fake medicines at Kenyan ports by 60 percent within five years. At GSK he pioneered a continent-wide signal-detection system that integrates national adverse-event databases, shortening safety-alert turnaround to under 48 hours.
He is a past chair of the Kenya Association of Pharmaceutical Industry and deputy board chair of the National Quality Control Laboratory, where he championed ISO 17025 accreditation and the rollout of rapid-testing minilabs to 15 county depots. Mwiti mentors regulators through the African Medicines Agency readiness programme and lectures on regulatory science at Jomo Kenyatta University. His mission remains clear: ensure every African patient receives medicines that are safe, effective, and ethically promoted.